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Infectious disease hospitals are the front line of the
treatment of infectious diseases and the basic net of
the infectious diseases’ treatment system. With the
incidence change of infectious dieases and introduction
of modern hospital management pattern, new patterns and
thoughts are needed in the construction and development
of infectious disease hospitals, that is ‘modernization,
digitalization, humanitilization, gardern-like and green’.
Modernization refers to more advanced equipments,
service establishements and service procedure. Advanced
equipments should cover the ﬁeld of treatment,
examination, test, which can improve the accuracy
of diagnosis and treatment greatly. Advanced service
establishements could help avoiding the cross infection to
certain extent and improve the efﬁciency. Advanced service
procedure is deemed to ensure the patients’ safety as they
seek medical service in the infectious disease hospitals to
the most extent and the design must obey the principle
of ‘tri-aera tri-line’. Digitalization includes three parts as
the digitalization of basic medical information, assistant
medical information and service system, which can help
improving the service efﬁciency greatly and making the
decision more wisely. Humanitilization means to respect
people’s basic need, to provide them with more comfortable
medical environment and the patients-oriented service
pattern. Gardern-like refers to more beautiful scene inside
hospitals. Green means none infection or none polution in
the infectious disease hospitals.
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Methicillin-resistant strains of Staphylococcus aureus
emerged soon after the introduction of methicillin into
clinical practice. This was followed from the mid-1970s
by outbreaks of MRSA infection in many countries, mostly
caused by a single epidemic strain being transferred
between hospitals. The picture of MRSA within the hospital
setting is now one of both epidemic and sporadic infection
caused by a broader range of strains.
The salient feature of the S. aureus genome is the presence
of a large number of mobile elements that often carry
pathogenic or drug resistance determinants, or both. MRSA
contain one resistance island called SCCmec, i.e. an
exogenous piece of DNA that may vary between 15 to 60 kb
and is absent from methicillin-susceptible staphylococci.
Five types of SCCmec were discriminated on the basis of
their structures. These ﬁve types are likely to mirror major
original MRSA clones. Notably, types I, II, and III were
shown to belong to hospital clones, and harbor multiple
resistance determinants. A limited number of MRSA lineages
has emerged from the transfer of SCCmec into successful
methicillin-susceptible S. aureus (MSSA) clones.
Methicillin resistance in MRSA strains is due to the horizontal
acquisition from an unidentiﬁed species of the mecA
gene, which encodes PBP2a, a novel PBP that is highly
resistant to inhibition by b-lactams and maintains cell wall
synthesis at normally lethal b-lactam concentrations. MRSA
strains are often heteroresistant to beta-lactam antibiotics
in that two subpopulations (one susceptible and the other
resistant) coexist within a culture.
b-lactam agents other than methicillin may appear active
in vitro, but are not effective clinically. Results for these
drugs should be reported as “resistant” or should not be
reported. This is because most cases of documented MRSA
infections have responded poorly to b-lactam therapy, or
because convincing clinical data have yet to be presented
that document clinical efﬁcacy for those agents.
The mecA gene is bracketed by one or two copies of IS431,
which are believed to serve as a gene collector and may
promote the local insertion of additional determinants, such
as antibiotic resistance genes. Thus, co-resistance to several
antibiotic classes is a typical feature of MRSA, although it
varies according to the different geographic regions.
MRSA rates are increasing worldwide and in different clinical
settings. MRSA were classically associated with hospitals or
long-term care facilities, and with invasive procedures such
as dialysis, indwelling catheters and prosthesis. The rare
MRSA in the community used to originate from health care
institutions.
“Classical” community-acquired MRSA (CA-MRSA) have been
spreading among healthy people in the community, mostly
via skin-to-skin contacts (close contact sports such as
wrestling and rugby, and prison inmates). Most CA-MRSA
appeared to contain the Panton Valentine Leukocidin (PVL)
gene, encoding for an extracellular product of S. aureus
responsible for skin infections and severe necrotising
pneumonia (also fatal cases).
However, the actual picture is far more complex, univocal
microbiological deﬁnition is puzzling (carriers and European
patients often harbour PVL-negative CA-MRSA) CA-MRSA are
invading hospital settings, differences between CA-MRSA
and HA-MRSA get smaller and antibiotic resistance (on novel
plasmids) is on the surge.
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